The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The disclosure includes compositions and methods based on use of a 5HTR agent, in combination with one or more other neurogenic agents, or anti-astrogenic agent, to stimulate or activate the formation of new nerve cells.
Platinum(IV) DMSO Complexes: Synthesis, Isomerization, and Agostic Intermediates
作者:Sarah H. Crosby、Guy J. Clarkson、Robert J. Deeth、Jonathan P. Rourke
DOI:10.1021/om901087m
日期:2010.4.26
cyclometalated Pt(II) complexes with S-bound DMSO ligands initially results in Pt(IV) complexes that retain the S-bound DMSO ligands in the same relative position. Isomerization reactions result in a rearrangement of the ligands to give O-bound DMSO complexes, with the DMSO trans to a cyclometalated carbon. X-ray structures representing the only two known examples of Pt(IV) complexes with O-bound DMSO